J 2017

Hematological Profile of Untreated or Ionizing Radiation-Exposed Cyclooxygenase-2-Deficient Mice

HOFER, M., Z. HOFEROVA, Ladislav DUŠEK, Karel SOUČEK, A. GRUZDEV et. al.

Basic information

Original name

Hematological Profile of Untreated or Ionizing Radiation-Exposed Cyclooxygenase-2-Deficient Mice

Authors

HOFER, M. (203 Czech Republic), Z. HOFEROVA (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, guarantor, belonging to the institution), Karel SOUČEK (203 Czech Republic, belonging to the institution) and A. GRUZDEV (840 United States of America)

Edition

Physiological research, Praha, Fyziologický ústav AV ČR, 2017, 0862-8408

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30105 Physiology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.324

RIV identification code

RIV/00216224:14110/17:00095137

Organization unit

Faculty of Medicine

UT WoS

000412736000013

Keywords in English

Cyclooxygenase-2; COX-2 knock-out mice; Hematopoiesis; Ionizing radiation; Post-irradiation inflammation

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 14:11, Soňa Böhmová

Abstract

V originále

We investigated hematopoiesis in untreated and ionizing radiation-exposed cyclooxygenase-2-deficient (COX-2 KO) mice. We performed a complex hematological analysis of 16 parameters in untreated COX-2 KO male mice or COX-2 KO male mice irradiated with the dose of 4 Gy of gamma-rays and their wildtype littermates. At baseline, hematopoiesis was increased in COX-2-deficient mice, but attenuated by irradation in COX-2-deficient mice compared to wildtype. To conclude, the anti-inflammatory action of the COX-2 genetic disruption plays a positive role in hematopoiesis under basal conditions but is detrimental following radiation exposure.

Links

GA16-12454S, research and development project
Name: Charakterizace a modifikace komplexní odpovědi buněk nádorů hlavy a krku na různá záření - krok kupředu ke kombinované personalizované (radio)terapii
Investor: Czech Science Foundation